Scarica l'app Stockscreener
17.25
0.00%
0.00
Precedente Chiudi:
$17.25
Aprire:
$17.4
Volume 24 ore:
3,135
Relative Volume:
0.89
Capitalizzazione di mercato:
$414.44M
Reddito:
$1.70M
Utile/perdita netta:
$-47.01M
Rapporto P/E:
-10.15
EPS:
-1.7
Flusso di cassa netto:
$-157.28M
1 W Prestazione:
-5.62%
1M Prestazione:
-3.10%
6M Prestazione:
-5.99%
1 anno Prestazione:
-19.20%
Intervallo 1D:
$17.25
$17.40
Intervallo di 1 settimana:
$17.25
$18.37
Portata 52W:
$13.30
$25.00
Puretech Health Plc Adr Stock (PRTC) Company Profile
Nome
Puretech Health Plc Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta PRTC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRTC
Puretech Health Plc Adr
|
17.25 | 440.64M | 1.70M | -47.01M | -157.28M | -1.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
379.29 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.60 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.82 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
641.30 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
289.46 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Puretech Health Plc Adr Stock (PRTC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-09-09 | Ripresa | Leerink Partners | Outperform |
Puretech Health Plc Adr Borsa (PRTC) Ultime notizie
PureTech Health (NASDAQ:PRTC) Shares Down 7.3% – Here’s What Happened - Defense World
PureTech Health names Robert Lyne as interim CEO as Chowrira departs - Investing.com
PureTech Health names Robert Lyne as interim CEO as Chowrira departs By Investing.com - Investing.com India
PureTech Health announces board leadership transition By Investing.com - Investing.com South Africa
PureTech Health announces board leadership transition - Investing.com
PureTech Health announces board chair Raju Kucherlapati steps down - Investing.com
PureTech Health issues shares to executives following RSU vesting - Investing.com
PureTech Health announces RSU vesting and share transactions by PDMR - Investing.com
PureTech set for Jefferies Global Healthcare Conference chat By Investing.com - Investing.com India
PureTech set for Jefferies Global Healthcare Conference chat - Investing.com
PureTech’s Deupirfenidone (LYT-100) Demonstrates Strong and Durable Efficacy as a Monotherapy with Favorable Tolerability in Phase 2b ELEVATE IPF Trial - Placera.se
PureTech research reveals gaps in IPF patient care - Investing.com
PureTech research reveals gaps in IPF patient care By Investing.com - Investing.com South Africa
PureTech Health PLC (PTCHF) (FY 2024) Earnings Call Highlights: Strong Financial Execution and ... By GuruFocus - Investing.com Canada
PureTech Health to release annual financial results April 30 - Investing.com
PureTech Health to release annual financial results April 30 By Investing.com - Investing.com South Africa
PureTech Health enlists Peel Hunt as joint broker - Investing.com
PureTech Health enlists Peel Hunt as joint broker By Investing.com - Investing.com India
Invesco Ltd: Form 8.3PureTech Health PLC; Opening Position disclosure - The Manila Times
PureTech Health in potential acquisition talks with Nordic Capital By Investing.com - Investing.com South Africa
PureTech Health in potential acquisition talks with Nordic Capital - Investing.com India
Nordic Capital XI ends pursuit of PureTech acquisition - Investing.com
PureTech Health issues shares to executives after RSU vesting - Investing.com India
PureTech Health issues shares to executives after RSU vesting By Investing.com - Investing.com South Africa
PureTech set for fireside chat at global healthcare event - Investing.com India
PureTech set for fireside chat at global healthcare event By Investing.com - Investing.com South Africa
FDA fast tracks PureTech's leukemia treatment - Investing.com
PureTech to present at J.P. Morgan Healthcare Conference By Investing.com - Investing.com India
PureTech reports positive LYT-200 trial results in AML/MDS - Investing.com
Rubrik Reports Q2 Results, Joins Ionis Pharmaceuticals, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
South Korea Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Europe Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Top Biotech Stocks: Exploring Innovation Opportunities - MarketBeat
PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share - Business Wire
symbol__ Stock Quote Price and Forecast - CNN
The definitive Boston biotech layoff tracker for 2023 - The Business Journals
This Emerging Market Could Be The Next Big Thing In Biotech - Barchart.com
Royalty Pharma and PureTech Health Enter KarXT Royalty Agreement for Up to $500M - Investing.com India
The Petri Dish: 1910 Genetics hires CBO; PureTech calls off merger - The Business Journals
Has Nextgen Healthcare (NXGN) Outpaced Other Medical Stocks This Year? - Nasdaq
Wall Street Analysts Predict an 82% Upside in PureTech Health PLC Sponsored ADR (PRTC): Here's What You Should Know - Nasdaq
PureTech Announces Annual Results for Year Ended December 31, 2020 - Samoa Observer
Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time - MarketBeat
Puretech Health Plc Adr Azioni (PRTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.79%
1.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):